They demonstrated that ApoE4 carriers are characterized by breakdown of the BBB prior to cognitive impairment and that high baseline markers of pericyte dysfunction in the cerebrospinal fluid (CSF) predicts future cognitive decline specifically in ApoE4 carriers, and not in non-carriers. Here, APOE is linked to Mental deterioration.